ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID
NODE_459_length_1363_cov_1.27523_3 # 1103 # 1279 # 1 # ID=459_3;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.599	NODE_459_length_1363_cov_1.27523_3 	1103	1279	+	Loose	400	21.557	MexL	30.77	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCACAACGTGATTGGCACCTACCTGCACGGTTCGCTGCTGCCGAAGAACCCGAAGATTTCGGACTACCTGATTGAGCAGGCGGCTAAGCGTAAGTTTGGCGAGTTCACGCCGAACACGATTGACGACTCGCTGGTGGAGAAGGCACGCGCTTCGGCTGCGTCTCGCCCCCGCTAG	VHNVIGTYLHGSLLPKNPKISDYLIEQAAKRKFGEFTPNTIDDSLVEKARASAASRPR	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	27.36	gnl|BL_ORD_ID|2092|hsp_num:0	2219
NODE_703_length_1189_cov_1.89771_4 # 1072 # 1188 # -1 # ID=703_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.316	NODE_703_length_1189_cov_1.89771_4 	1072	1188	-	Strict	500	19.631	OXA-330	100.0	3001518	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GAACAAATAAAAAAGGAGAGTATTTCTACTCTCCCTTTTTCTAAGAATCAAAATTCTACTAAAATTAGTAATGCTAACACTGCACGACGGTTTTTAGAGTATGCTGCTTCATCGTGA	EQIKKESISTLPFSKNQNSTKISNANTARRFLEYAASS	MYKKALIVATSILFLSACSSNLVKQHQIHSISANKSSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQFAYQLAHKTLPFSKNVQEQVQSMVFIEKKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTSSSIRKEIAYKGLEQLGIL	13.92	gnl|BL_ORD_ID|51|hsp_num:0	61
NODE_1284_length_960_cov_5.85193_1 # 1 # 81 # 1 # ID=1284_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.469	NODE_1284_length_960_cov_5.85193_1 	1	81	+	Strict	2200	20.0162	Bifidobacterium ileS conferring resistance to mupirocin	100.0	3003730	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic resistant isoleucyl-tRNA synthetase (ileS)	CGTCTTCTCTATACTCTGCCTACAGGGGGATTTGTGAAATATCTCTGCACTGATCACCCAGGTGATGGAAGTCTTGTCTAG	RLLYTLPTGGFVKYLCTDHPGDGSLV	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	2.35	gnl|BL_ORD_ID|2128|hsp_num:0	2278
NODE_2068_length_795_cov_1.07027_3 # 554 # 793 # -1 # ID=2068_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.342	NODE_2068_length_795_cov_1.07027_3 	554	793	-	Strict	600	162.925	CfxA2	100.0	3003002	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	CTTCTTGATAAAGAAGGGGTTGTTATAGCGCATAAGACAGGTTCAGGTTATGTTAATGAAAATGGTGTTCTTGCAGCTCACAATGATGTTGCCTATATATGTCTGCCTAATAATATCAGTTATACCTTAGCGGTATTTGTTAAGGATTTCAAGGGAAATGAATCACAAGCGTCACAATATGTTGCGCATATATCAGCTGTAGTATATTCTTTATTAATGCAAACTTCAGTAAAATCTTAA	LLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	24.61	gnl|BL_ORD_ID|162|hsp_num:0	174
NODE_3037_length_673_cov_1.32039_3 # 580 # 672 # 1 # ID=3027_3;partial=01;start_type=ATG;rbs_motif=TAA;rbs_spacer=8bp;gc_cont=0.366	NODE_3037_length_673_cov_1.32039_3 	580	672	+	Loose	275	21.557	AAC(6')-Ic	38.1	3002549	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGGAATCACAAAATTTAAGCAAAGATGACACCACTGCATGGCTCAAAAAAATGCAGGAAATCTTCCCTGATTTTTCACCAAACGACATCTTA	MESQNLSKDDTTAWLKKMQEIFPDFSPNDIL	MIVICDHDNLDAWLALRTALWPSGSPEDHRAEMREILASPHHTAFMARGLDGAFVAFAEVALRYDYVNGCESSPVAFLEGIYTAERARRQGWAARLIAQVQEWAKQQGCSELASDTDIANLDSQRLHAALGFAETERVVFYRKTLG	21.23	gnl|BL_ORD_ID|1245|hsp_num:0	1299
NODE_3117_length_665_cov_1.63443_1 # 2 # 262 # -1 # ID=3105_1;partial=10;start_type=ATG;rbs_motif=AAAA;rbs_spacer=4bp;gc_cont=0.410	NODE_3117_length_665_cov_1.63443_1 	2	262	-	Strict	950	180.644	mel	100.0	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTATAATGCTGCTAAAACCCTAGAGCACAGGATTGCGGCCTTAGGAAAAGTAGAAGCTCCGGAAGGCATTCGCAGAATTCGTTTCAGGCAAAGTAAAGCATTGGAGCTCCATAATCCATACCCTATAGTCGGTGCAGAAATTAATAAAGTATTTGGGGATAAGGCTCTGTTTGAAAATGCATCTTTTCAAATTCCGTTAGGAGCAAAAGTGGCGTTAACTGGTGGTAATGGAATCGGAAAAACAACTTTAATCCAAATG	MYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQM	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	17.86	gnl|BL_ORD_ID|1177|hsp_num:0	1231
NODE_3117_length_665_cov_1.63443_2 # 281 # 664 # -1 # ID=3105_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.391	NODE_3117_length_665_cov_1.63443_2 	281	664	-	Strict	950	236.884	mel	96.75	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTAGCGGATGAACCTACGAGCCATTTAGACCGTGAAGGAATTGATTTTCTAATAGGACAGCTAAAATATTTTACAGGTGCACTGTTAGTTATTAGCCATGACCGCTATTTTCTTGATGAAATAGTAGATAAAATATGGGAACTGAAAGATGGCAAAATCACTGAGTATTGGGGAAACTATTCTGATTATCTTCGTCAGAAAGAGGAAGAACGTAAGAGCCAAGCTGCAGAATACGAACAATTTATTGCGGAACGTGCCCGATTGGAAAGGGCTGCGGAGGAAAAGCGAAAACAGGCTCGTAAAATAGAACAGAAGGCAAAGGATTCTTCTAAAGAAAAAAAAGTACATGAAGACGGAGGGCGTTTAGCTCTCAAAAATCAATAA	LADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKDSSKEKKVHEDGGRLALKNQ	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	26.08	gnl|BL_ORD_ID|1177|hsp_num:0	1231
NODE_3286_length_647_cov_2.12838_1 # 393 # 647 # 1 # ID=3270_1;partial=01;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.443	NODE_3286_length_647_cov_2.12838_1 	393	647	+	Strict	800	168.703	mefA	95.29	3000615	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGGGACCTGCCATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCCGATTTAATTATCGCAGCAGCTGGTGCAGTGCTTGCTATTGTTGCATTCTGTATGGAGCTACCTGTCTGGATGATTATGATAGTATTGTTTATCCGTAGCATTGGAACAGCTTTTCATACCCCAGCACTCAATGCGGTTACACCACTTTTAGTACCAGAAGAACAGCTAACGAAATGCGCAGGCTATAGTCAG	LGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQ	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK	20.99	gnl|BL_ORD_ID|1891|hsp_num:0	1976
NODE_3488_length_627_cov_2.07692_1 # 3 # 269 # 1 # ID=3462_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.442	NODE_3488_length_627_cov_2.07692_1 	3	269	+	Loose	250	25.0238	arr-8	36.59	3002853	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	AAGAGCTTTGAGGATTTGTATAAGCGCGGTGGTTGGATTATTGATGGCATTGACAACTATGTTGCTGATGGAAATCCGTGGTCTGAGGATGGGGAAACCTATTTTTGGAAGGCTTATCGCGAGTGGAATTATATAACTCTTGTGGAGCCTACTGGCGAGTGGCACAGAGACGTCAATATCCAGAAGGATAACGATACGTGGAAGTTTGAGTTTAAGTACTCCGATTCTTCCTGGAAGATTGTTGGCTGCGAACAGGTAGATGACTAA	KSFEDLYKRGGWIIDGIDNYVADGNPWSEDGETYFWKAYREWNYITLVEPTGEWHRDVNIQKDNDTWKFEFKYSDSSWKIVGCEQVDD	MIKDWIPTTHENCKKMQGPFYHGTKAKLSVGELLTTGFNTHFEEGRTLKHVYFSAMLEPAIWGAELAVSLSGLDGRGYIYLVEPTGPFEDDPNLTNKKFPGNPTMSYRTSEPLQIVGVVEEWEGHSAEALKAMLDSLENLERNGLHVIYD	58.67	gnl|BL_ORD_ID|119|hsp_num:0	133
NODE_3585_length_618_cov_2.0675_1 # 3 # 80 # -1 # ID=3552_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.487	NODE_3585_length_618_cov_2.0675_1 	3	80	-	Strict	790	53.9138	mtrC	96.15	3000810	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGGGCTTGTATGTGCGCGTATTGATGGAACAAGTGGCAGTGGATAATGCATTTGTAGTGCCGCAACAAGCAGTT	MPGLYVRVLMEQVAVDNAFVVPQQAV	MAFYAFKAMRAAALAAAVALVLSSCGKGGDAAQGGQPAGREAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQSKVSEGTLLNAGDATVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFDDGTVYPEKGRLLFADPAVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVPQQAVTRGAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVVEGISIAGITGAKKVTPKEWASSENQAAAPQSGVQTASEAKPASEAK	6.31	gnl|BL_ORD_ID|1280|hsp_num:0	1340
NODE_4438_length_558_cov_1.75348_2 # 354 # 557 # -1 # ID=4314_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.397	NODE_4438_length_558_cov_1.75348_2 	354	557	-	Loose	500	21.1718	BUT-1	63.16	3004294	protein homolog model	n/a	n/a		antibiotic inactivation		GCAGTAACAATACCTCTTGGTATAGTATCTGCAAAATATCAGGATTCTTGGATCGATCATGGTATACGTCTAGTAACGTTCTTGGCCTTAGCTATTCCTGGGTTCTGGGTCGGTTTATTATTACTGTACTTATTCGGTGTTAAATTACAGCTAGTGTCGGTAACGAATACCAATGGCTTTTCTGCCTATGTATTCCCGCGGTAA	AVTIPLGIVSAKYQDSWIDHGIRLVTFLALAIPGFWVGLLLLYLFGVKLQLVSVTNTNGFSAYVFPR	MCRTLCHVTYGRFSMMKKTLCCALVLSASFSAFAAQKTLSDKQLEEAVNQTLKPMITAQAIPGMAVAVIYQGKPHYFTYGVADIAKNQPVTTQTIFELGSVSKTFTGVLGGDIVARGEVKLSDPAMKYWPELTGKQWQGITLLDLATYTAGGLPLQVPDEVDNQAALLKFYQNWQPDWAPGTRRQYANSSIGLFGALAVKPSGMTFNDAMRQRVLQPLNLKHTWLTVPASEENHYAWGYRDGKAMHVGPGMLDTEAYGVKSTIEDMASWVQYNMNPQQVKQPTLQKGLEIAQSRYWRSGSMYQGLGWEMLNWPVAAATVINGSDNKVALAASPVTAIEPPVAPVKASLVHKTGSTNGFGAYVAFIPEKQIGIVMLANKMYPNTERVKAANTLLNTLQ	16.88	gnl|BL_ORD_ID|2345|hsp_num:0	2846
NODE_4871_length_533_cov_1.2113_2 # 293 # 532 # 1 # ID=4685_2;partial=01;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.375	NODE_4871_length_533_cov_1.2113_2 	293	532	+	Strict	600	121.709	CfxA3	98.33	3003003	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	TTGCCAAATCGTGAGGGTCCTAAGTTCTATGATAAGGTGAAGCAGGGGTTATTTCCAAAGTTTGTATTTTCATTGTTCCATAAATCAGCGACAAAAGATAGCGCAAATCCTCCTTTAACAAATGTTTTGACTGATAGCATTTCTCAAATTGTCTCAGCTTGTCCTGGCGAAATTGGTGTGGCGGTTATTGTTAATAACAGAGATACGGTTAAGGTCAATAATAAGAGTGTTTATCCTATG	LPNREGPKFYDKVKQGLFPKFVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPM	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	24.92	gnl|BL_ORD_ID|1813|hsp_num:0	1895
NODE_5368_length_509_cov_1.4141_1 # 3 # 395 # 1 # ID=5075_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.354	NODE_5368_length_509_cov_1.4141_1 	3	395	+	Loose	375	23.0978	fusD	26.67	3003731	protein homolog model	n/a	n/a	fusidic acid	antibiotic inactivation	fusidic acid inactivation enzyme	TACAATCATAAGAATAGATATAATAATCCCAGAGATATTGAGATTTATAAGCGATTACCGCAAGGGGCAAACTCTTTGCATCCTTCTATTGAAGATATTATGCCATACAAAAGTCGAAATGGCATCTTCAAAGATAAATATTTTAAATTGGATGAAACACAAATTTGTAAGACAATAACTTCTCACATGAAGTATGATTGTAATATGTATATTCATCCTTGGGAAGCTCGTGGACTTAGTCCGCGTGAGGCAGCACGTATCCAGACATTCCCTGATGACTATATTATAACAGGGGCTCAAAATATGTGGTATGCTCAAGTAGGTAATGCTGTTCCTGTGAAACTTGCCAAAGCTATTGGTGATGGATTAATGAAATTCATAGATAGGGTATAA	YNHKNRYNNPRDIEIYKRLPQGANSLHPSIEDIMPYKSRNGIFKDKYFKLDETQICKTITSHMKYDCNMYIHPWEARGLSPREAARIQTFPDDYIITGAQNMWYAQVGNAVPVKLAKAIGDGLMKFIDRV	MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILSTFNSRNTTIRSNVEKLMNVQLTKEQAQKILTTIQMYVKPFEHPSNKQVTNLFKKVKKLKTPLISDEVLQTSTYIGWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKSFCSICNKESRVALFMRKTRTGNDGQYTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ	61.03	gnl|BL_ORD_ID|2109|hsp_num:0	2248
